Jones James bought CPIX
August 7, 2025 · Form 4 insider transaction
Jones James bought 13 shares of Cumberland Pharmaceuticals Inc. at $3.14 per share, a transaction worth $40.82. The trade was recorded as open-market purchase under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 36 days after the transaction.
Direction
Acquired (buy-side)
Shares
13
Price
$3.14
Total value
$40.82
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 7, 2025
Filing dateSeptember 12, 2025
Shares owned after43,741
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024.